首页 | 本学科首页   官方微博 | 高级检索  
     

抗真菌新药联苯苄唑(Bifonazal)治疗头皮脂溢性皮炎的临床和实验研究
引用本文:陈家秀,杨凤翔,袁承晏. 抗真菌新药联苯苄唑(Bifonazal)治疗头皮脂溢性皮炎的临床和实验研究[J]. 重庆医科大学学报, 1990, 0(3)
作者姓名:陈家秀  杨凤翔  袁承晏
作者单位:重庆医科大学第一医院皮肤科教研室(陈家秀,杨凤翔),重庆医科大学第一医院皮肤科教研室(袁承晏)
摘    要:18例头皮脂溢性皮炎,使用1%联苯(艹 卡)唑酊剂外用治疗,全部取得临床痊愈,12例病原菌培养转阴性。对从头皮屑培养出的糠秕孢子菌6株作了最小抑菌浓度(MIC)测定。联苯苄唑对糠秕孢子菌的MIC为0.25—0.5μg/me,略优于酮康唑和咪康唑。 临床和实验室结果表明:联苯苄唑外用治疗头皮脂溢性皮炎是一种有希望的药物;对糠秕孢子菌是脂溢性皮炎的条件致病菌的学说提供新的支持

关 键 词:抗真菌药  脂溢性皮炎  糠秕孢子菌

CLINICAL AND LABORATORY RESEARCH ON BIFONAZOL FOR DERMATITS SEBORRHEICA CAPITIS
Chen Jiaxiu ef al. CLINICAL AND LABORATORY RESEARCH ON BIFONAZOL FOR DERMATITS SEBORRHEICA CAPITIS[J]. Journal of Chongqing Medical University, 1990, 0(3)
Authors:Chen Jiaxiu ef al
Abstract:1 8 casts of dermatitis seborrfceica capitis were topically treated with 1% Bifon- azol tincture. All the cases were cured clinically and of the cases turned negative in pathogen cultures. The MIC of Bifonazol to piturosponim ovale were tested in six strains isolated from dandruff.The MIC Bifonazol to Microsporum is 0.25-0.5/ml, slightly superior to Ketokon-azol and Micooazol.The results show that Bifonazol is a hopeful drug for dermatitis seborrheica capi tis and also support the theory that pitytosporem cvale is an opportunistic patogen for dermatitis seborrheica capitis
Keywords:Antimycotic  Dermatitis Seborrheica Capitis  Pityrosporum  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号